Insilico, a pioneering company, has incorporated the revolutionary AlphaFold technology to predict protein shapes using AI. Petrina Kamya showcased how the company utilizes AlphaFold to generate potential new drugs entirely through computer simulations. Insilico has leveraged this technology to earn substantial revenue through licensing fees for its small molecule drug candidates. With successful advances in clinical trials, the company is poised to earn even more. Furthermore, Insilico is exploring partnerships with countries like the UAE to target diseases specific to their populations. The company is also involved in a unique docuthon project, seeking to crowdsource a documentary about its journey and impact.
Menu
The startup that wants to cure diseases and slow aging, with the help of AI
Key Points:
- Insilico has successfully integrated AlphaFold technology, a groundbreaking AI project by DeepMind, to predict protein structures and develop potential new drugs entirely on a computer.
- The company has earned significant revenue through licensing fees for its small molecule drug candidates, targeting diseases such as breast cancer, inflammatory bowel disease, and anemia of chronic kidney disease.
- Insilico is exploring partnerships with countries like the UAE to advance drug discovery targeting diseases specific to their populations, and is involved in a docuthon project to crowdsource a documentary about its journey and impact.
Summary:
HEALTH
WORLD AFFAIRS
TECHNOLOGY
CREATIVEAI INFLUENCERS
John Carmack 
Clem Delangue
Timnit Gebru
Jensen Huang
Lila Ibrahim
Robert Miles 
Kevin Scott
AI MODELS
Popular Large Language Models
ALPACA (Stanford)
BARD (Google)
Gemini (Google) 
GPT (OpenAI)
LLaMA (Meta)
Mixtral 8x7B (Mistral)
PaLM-E (Google)
VICUNA (Fine Tuned LLaMA)
Popular Image Models
Stable Diffusion (StabilityAI)
Leaderboards
NOTABLE AI APPS
Chat
Image Generation / Editing
Audio / Voice Generation
Video Generation
DAILY LINKS TO YOUR INBOX
EMAIL: [email protected]
©2024 The Horizon